CAL
RMD icon

Capital Advisors Ltd’s ResMed RMD Stock Holding History

Capital Advisors Ltd’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Buy
206
+2
+1% +$415 ﹤0.01% 554
2026
Q1 		$46K Hold
204
– – 0.01% 517
2025
Q4 		$49K Hold
204
– – 0.01% 482
2025
Q3 		$56K Hold
204
– – 0.01% 453
2025
Q2 		$53K Hold
204
– – 0.01% 460
2025
Q1 		$46K Hold
204
– – 0.01% 473
2024
Q4 		$47K Hold
204
– – 0.01% 467
2024
Q3 		$50K Sell
204
-8
-4% -$1.79K 0.01% 455
2024
Q2 		$41K Buy
212
+7
+3% +$1.42K 0.01% 479
2024
Q1 		$41K Buy
205
+5
+3% +$916 0.01% 471
2023
Q4 		$34K Sell
200
-7
-3% -$1.08K ﹤0.01% 482
2023
Q3 		$31K Buy
207
+42
+25% +$7.59K ﹤0.01% 481
2023
Q2 		$36K Buy
165
+14
+9% +$3.12K 0.01% 477
2023
Q1 		$33K Hold
151
– – 0.01% 413
2022
Q4 		$31K Sell
151
-10
-6% -$2.2K 0.01% 421
2022
Q3 		$35K Buy
161
+14
+10% +$3.19K 0.01% 397
2022
Q2 		$31K Buy
147
+140
+2,000% +$29.8K 0.01% 399
2022
Q1 		$0 Sell
7
-142
-95% -$34.3K ﹤0.01% 1164
2021
Q4 		$39K Buy
+149
New +$38.7K 0.01% 376

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Capital Advisors Ltd's RMD Position: Q2 2026 in Review

Capital Advisors Ltd increased its ResMed (RMD) stake by 0.98% in Q2 2026, buying an estimated $415 and bringing the position to 206 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Capital Advisors Ltd first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $56K in Q3 2025. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Capital Advisors Ltd held 206 shares of ResMed worth $40K as of Q2 2026.
  • Capital Advisors Ltd bought 2 ResMed shares in Q2 2026, an estimated $415.
  • ResMed made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #554 holding.
  • Capital Advisors Ltd first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • Capital Advisors Ltd's ResMed position peaked at $56K in Q3 2025.
  • 141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.